Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 7993 - 8000 of 12091 results

EU-US Privacy Shield to Launch August 1, Replacing Safe Harbor
July 25, 2016| Alert| Viewpoint

FDA Adjustment to Orphan Drug Review May Indicate Increased Scrutiny of Designations
July 22, 2016| Blog| Viewpoint

Summer Travel Tips Released by CBP
July 22, 2016| Blog| Viewpoint

3 Things To Know About Immigration Fine And Fee Increases
July 22, 2016| News

CPSC Majority Holds Firm on Civil Penalties
July 22, 2016| News

FDA Releases Draft Guidance on Codevelopment of Therapeutic Products and Screening Tests
July 21, 2016| Blog| Viewpoint

Dionne Lomax named Vice Chair of Publications for the AHLA Antitrust Practice Group
July 21, 2016| Blog| Viewpoint

The Emerging HIPAA Security Threat Presented by . . . Pikachu?
July 21, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
